| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 694619 | Null | 0.0352028253287042 | -0.24627722 |
| NSC 718564 | Null | 0.0352028253287042 | -0.064632452 |
| NSC 718781 | Erlotinib hydrochloride | 0.0352028253287042 | 0.20353516 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0352028253287042 | -0.10955232 |
| NSC 725098 | Null | 0.0352028253287042 | -0.30266156 |
| NSC 726089 | 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate | 0.0352028253287042 | -0.32357791 |
| NSC 731704 | 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. | 0.0352028253287042 | -0.21374377 |
| NSC 732936 | 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0352028253287042 | -0.19450381 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.0352028253287042 | -0.39210481 |
| NSC 741425 | 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide | 0.0352028253287042 | -0.13168201 |